Potential Impact on Lipoprotein Subfractions in Type 2 Diabetes

Abstract

Reduction in body weight, improvement of blood glucose levels, and increases in very large HDL and large HDL subclasses were observed after canagliflozin treatment. These beneficial changes might contribute to subsequent suppression of cardiovascular outcomes.